We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Cooper Companies
COO
$10.1B
| $15.6M | 0.04% |
178,840
-2,414
| -1% | -$225K |
|
452
Clear Secure
YOU
$4.28B
| $15.5M | 0.04% |
830,751
+274,566
| +49% | +$4.97M |
|
453
CF Industries
CF
$20.5B
| $15.5M | 0.04% |
208,982
-157,069
| -43% | -$12.2M |
|
454
SPX Corp
SPXC
$8.93B
| $15.4M | 0.04% |
108,323
-39
| -0% | -$5.15K |
|
|
B
455
Barrick Mining
B
$70.3B
| $15.4M | 0.04% |
922,300
-103,173
| -10% | -$1.75M |
|
456
Medtronic
MDT
$120B
| $15.4M | 0.04% |
195,324
+10,586
| +6% | +$868K |
|
457
GitLab
GTLB
$8.18B
| $15.4M | 0.04% |
308,859
+28,431
| +10% | +$1.48M |
|
458
Neurocrine Biosciences
NBIX
$15.2B
| $15.3M | 0.04% |
111,055
+3,818
| +4% | +$524K |
|
459
Columbia Sportswear
COLM
$2.89B
| $14.9M | 0.04% |
188,911
+12,353
| +7% | +$999K |
|
460
United Rentals
URI
$61.6B
| $14.9M | 0.04% |
23,054
+2,438
| +12% | +$1.62M |
|
|
GTM
461
ZoomInfo Technologies
GTM
$1.22B
| $14.8M | 0.04% |
1,160,649
+118,286
| +11% | +$1.65M |
|
462
Hims & Hers Health
HIMS
$6.5B
| $14.8M | 0.04% |
730,955
-142,606
| -16% | -$2.37M |
|
463
Yext
YEXT
$632M
| $14.7M | 0.03% |
2,748,420
+1,275,348
| +87% | +$6.87M |
|
|
DOCU
464
DocuSign
DOCU
$13.4B
| $14.7M | 0.03% |
274,516
+156,457
| +133% | +$8.82M |
|
465
Church & Dwight Co
CHD
$22.4B
| $14.7M | 0.03% |
141,450
+2,159
| +2% | +$228K |
|
466
UiPath
PATH
$7.42B
| $14.5M | 0.03% |
1,143,574
+470,740
| +70% | +$8.14M |
|
467
Hyster-Yale Materials Handling
HY
$599M
| $14.4M | 0.03% |
207,148
-246
| -0.1% | -$16.8K |
|
468
Albertsons Companies
ACI
$6.23B
| $14.4M | 0.03% |
730,007
+19,099
| +3% | +$390K |
|
469
Liberty Energy
LBRT
$3.18B
| $14.2M | 0.03% |
681,681
-46,280
| -6% | -$1.03M |
|
470
Coupang
CPNG
$26.4B
| $14.2M | 0.03% |
679,601
+425,416
| +167% | +$9.22M |
|
471
RLI Corp
RLI
$5.63B
| $14M | 0.03% |
199,120
-5,856
| -3% | -$419K |
|
472
McDonald's
MCD
$179B
| $14M | 0.03% |
54,928
-69,419
| -56% | -$18.4M |
|
473
Nu Skin
NUS
$231M
| $14M | 0.03% |
1,323,542
+698,722
| +112% | +$8.85M |
|
474
PBF Energy
PBF
$8.86B
| $13.9M | 0.03% |
302,565
+5,266
| +2% | +$270K |
|
475
Agilent Technologies
A
$42.4B
| $13.9M | 0.03% |
106,908
+6,583
| +7% | +$921K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.